Protein Description

Gene Symbol INHBB
Entrez ID 3625
Uniprot ID P09529
Description inhibin beta B
Chromosomal Location chr2: 120,346,143-120,351,808
Ontology GO ID GO Term Definition Evidence

BP

GO:0001541

ovarian follicle development

The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.

NAS

BP

GO:0006952

defense response

Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.

TAS

BP

GO:0009267

cellular response to starvation

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.

ISS

BP

GO:0009612

response to mechanical stimulus

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.

IDA

BP

GO:0010862

positive regulation of pathway-restricted SMAD protein phosphorylation

Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.

IBA

BP

GO:0030154

cell differentiation

The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.

NAS

BP

GO:0032869

cellular response to insulin stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.

ISS

BP

GO:0032924

activin receptor signaling pathway

A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IDA

BP

GO:0040007

growth

The increase in size or mass of an entire organism, a part of an organism or a cell.

IEA

BP

GO:0042981

regulation of apoptotic process

Any process that modulates the occurrence or rate of cell death by apoptotic process.

IBA

BP

GO:0043408

regulation of MAPK cascade

Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade.

IBA

BP

GO:0044320

cellular response to leptin stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.

IEA

BP

GO:0045444

fat cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.

ISS

BP

GO:0046676

negative regulation of insulin secretion

Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.

ISS

BP

GO:0046881

positive regulation of follicle-stimulating hormone secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.

IPI

BP

GO:0046882

negative regulation of follicle-stimulating hormone secretion

Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of follicle-stimulating hormone.

IPI

BP

GO:0048178

negative regulation of hepatocyte growth factor biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hepatocyte growth factor.

IDA

BP

GO:0048468

cell development

The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.

IBA

BP

GO:0048599

oocyte development

The process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.

IEA

BP

GO:0060279

positive regulation of ovulation

Any process that activates or increases the frequency, rate or extent of ovulation, the release of a mature ovum/oocyte from an ovary.

ISS

BP

GO:0060395

SMAD protein signal transduction

The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.

IBA

BP

GO:2001235

positive regulation of apoptotic signaling pathway

Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.

IEA

CC

GO:0005576

extracellular region

The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

TAS

CC

GO:0005615

extracellular space

That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

IBA

CC

GO:0048471

perinuclear region of cytoplasm

Cytoplasm situated near, or occurring around, the nucleus.

IDA

CC

GO:0071944

cell periphery

The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures.

IEA

MF

GO:0005125

cytokine activity

Functions to control the survival, growth, differentiation and effector function of tissues and cells.

TAS

MF

GO:0005160

transforming growth factor beta receptor binding

Interacting selectively and non-covalently with the transforming growth factor beta receptor.

IBA

MF

GO:0005179

hormone activity

The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.

TAS

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008083

growth factor activity

The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.

IEA

MF

GO:0042803

protein homodimerization activity

Interacting selectively and non-covalently with an identical protein to form a homodimer.

IPI

MF

GO:0046789

host cell surface receptor binding

Interacting selectively and non-covalently with a receptor on the host cell surface.

TAS

Domain ID Description

IPR000381

Inhibin, beta B subunit

IPR001111

TGF-beta, propeptide

IPR001839

Transforming growth factor-beta, C-terminal

IPR015615

Transforming growth factor-beta-related

IPR017948

Transforming growth factor beta, conserved site

IPR029034

Cystine-knot cytokine

Pathway ID Pathway Term Pathway Source

hsa04060

Cytokine-cytokine receptor interaction

KEGG

hsa04350

TGF-beta signaling pathway

KEGG

hsa04550

Signaling pathways regulating pluripotency of stem cells

KEGG

WP2324

AGE/RAGE pathway

WikiPathways

WP3927

BMP Signaling Pathway in Eyelid Development

WikiPathways

No diseases found.

No tissues found.

Database Name

DisGeNET

DGA

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

TGFB1

7040

P01137

0.00

TGFB3

7043

P10600

0.00

ACVR1

90

Q04771

0.52

INHA

3623

P05111

0.52

INHBA

3624

P08476

0.52

INHBB

3625

P09529

0.52

FNTA

2339

P49354

0.63

ACVR2A

92

P27037

0.83

FST

10468

P19883

0.00

INHBC

3626

P55103

0.52

IGSF1

3547

Q8N6C5

0.55

ACVR1C

130399

Q8NER5

0.65

ACVR2B

93

Q13705

0.73

ACVR1B

91

P36896

0.84